Aurora Cannabis obtains further Health Canada production licence

Aurora Cannabis has obtained a Health Canada production licence for the Aurora Eau facility in Lachute, Quebec.

With the latest licence, Aurora currently has seven licensed production facilities with a combined production capacity of more than 160,000kg per year.

The 48,000ft² Aurora Eau facility has a production capacity of 4,500kg a year.

This facility has been designed to optimally accommodate production parameters of ‘exotic’ cultivars, new strains that are yet to be launched by the company, and new genetics that are currently under development.

Aurora CEO Terry Booth said: “We are proud of the achievements at Aurora Eau, and with seven production licences we are exceptionally well-positioned to continue executing on our early mover advantage, in both the Canadian and the international markets.

“With large-scale production scaling up at Aurora Sky, we have the ability to dedicate production from Aurora Eau to niche markets, thereby growing our brand recognition and enhancing our margin profile.

“Our new oils production licence at Bradford further increases our capacity to produce higher margin oils, and drive growth.”

Constructed on 46 acres of prime agricultural land, Aurora has the right to purchase for $136,000 to undertake future expansion.  This would help the firm to expand its footprint in Quebec, providing additional capacity to support future product development and distribution.

Additionally, Aurora noted that its wholly owned subsidiary MedReleaf has also secured oils production licence for its Bradford facility (MedReleaf Bradford), which is a 28,000 kg per annum cultivation facility.

Aurora also has other facilities that are currently under development, taking the total funded capacity to more than 500,000kg per annum.

The firm plans to continue its focus on obtaining EU GMP certification, as part of its commitment to the Aurora Standard and further supply chain diversification.

Until now, Aurora has two EU GMP cultivation facilities in Canada, alongside an EU GMP certified plant in Germany, which is operated by its wholly owned subsidiary Aurora Europe for the import and distribution of cannabis.